An EPS-accretive acquisition can destroy buyer value
EPS accretion measures accounting earnings per share, not acquisition value. Debt financing can lift recurring EPS while price and integration costs exceed the value of the acquired cash flows.
Earnings-per-share accretion is an increase in the buyer’s earnings per share after an acquisition on the specified accounting or adjusted basis. It does not establish that the acquired cash flows are worth more than the price and costs paid to obtain them.
Financing can increase recurring EPS without increasing business value
Take a buyer earning $20 million annually with 10 million shares outstanding. Its earnings per share, or EPS, is $2.00.
The buyer acquires a debt-free target for $60 million, financed entirely with new borrowing at 5%. Assume the target adds $5 million of annual earnings, there are no tax effects, and the buyer issues no shares.
Annual interest on the acquisition debt is $3 million. Recurring combined earnings become $20 million plus $5 million minus $3 million, or $22 million. With the same share count, recurring EPS rises to $2.20, a 10% increase.
The calculation establishes that target earnings exceed the specified financing expense. It has not established that $60 million is a good price for the target’s risk and cash flows.
The investment case must include price, timing, and required return
Continue with a constructed case in which the target’s $5 million of earnings also equals annual cash flow before acquisition financing, after all required operating reinvestment. Assume those cash flows begin one year after acquisition, continue indefinitely without growth, and require a 10% return for their risk.
Their present value is $5 million divided by 10%, or $50 million. Add $5 million of immediate integration cost to the $60 million purchase price. The total investment is $65 million, giving net present value of minus $15 million.
The ongoing EPS calculation remains accretive, but the acquired cash flows are worth less than the all-in investment under the stated assumptions. A current-period charge for integration can also reduce reported EPS; the $2.20 figure describes the recurring period after that charge.
Match the cash-flow and financing perspectives
The valuation above discounts cash flows before financing at the required return for those cash flows. It does not subtract acquisition interest again from that same enterprise-value calculation.
An equity valuation instead uses cash flows after debt service and the corresponding equity return requirement. Mixing an enterprise cash-flow measure with an equity discount rate, or counting financing costs twice, produces a different result through inconsistent arithmetic rather than a different economic case.
Synergies need an incremental baseline
Forecast savings add value only to the extent they exceed implementation costs, ongoing replacement costs, and other effects relative to the businesses’ standalone path. Growth that would have occurred without the transaction is not an acquisition benefit.
Purchase-accounting adjustments can also change reported earnings without changing operating cash in the same period. An assessment must reconcile reported EPS, adjusted EPS, integration spending, cash realization, and remaining forecasts.
The second-order effect is that a transaction can improve the metric used to promote it while reducing buyer value. EPS accretion is an output of accounting and financing assumptions; investment value requires a separate discounted cash-flow comparison.
Questions
- Can an EPS-accretive acquisition destroy value?
- Yes. Target earnings can exceed financing expense while the purchase price and integration costs exceed the risk-adjusted value of the acquired cash flows.
- Does a cheap borrowing rate justify paying a higher acquisition price?
- No. A low borrowing rate alone does not justify a higher price. The cash flows still need to support the total investment at a return appropriate to their risk.
- Is all post-acquisition growth a synergy?
- No. A synergy is incremental to the standalone alternative. Growth that would have occurred without the deal cannot all be credited to the acquisition.